P573-2162 Screening compound: 2-{2-[4-(4-methoxyphenyl)piperazin-1-yl]-2-oxoethyl}-7-(pyrrolidin-1-yl)-2H,3H-[1,2,4]triazolo[4,3-a]pyrimidin-3-one

P573-2162 Screening compound: 2-{2-[4-(4-methoxyphenyl)piperazin-1-yl]-2-oxoethyl}-7-(pyrrolidin-1-yl)-2H,3H-[1,2,4]triazolo[4,3-a]pyrimidin-3-one
P573-2162 Screening compound: 2-{2-[4-(4-methoxyphenyl)piperazin-1-yl]-2-oxoethyl}-7-(pyrrolidin-1-yl)-2H,3H-[1,2,4]triazolo[4,3-a]pyrimidin-3-one alternative view

Chemical Structure Depiction of ChemDiv screening compound P573-2162
2-{2-[4-(4-methoxyphenyl)piperazin-1-yl]-2-oxoethyl}-7-(pyrrolidin-1-yl)-2H,3H-[1,2,4]triazolo[4,3-a]pyrimidin-3-one

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

P573-2162

Molecular Formula

C22H27N7O3 (C22 H27 N7 O3)

Compound Name

2-{2-[4-(4-methoxyphenyl)piperazin-1-yl]-2-oxoethyl}-7-(pyrrolidin-1-yl)-2H,3H-[1,2,4]triazolo[4,3-a]pyrimidin-3-one

IUPAC name

2-{2-[4-(4-methoxyphenyl)piperazin-1-yl]-2-oxoethyl}-7-(pyrrolidin-1-yl)-2H3H-[124]triazolo[43-a]pyrimidin-3-one

SMILES

COc(cc1)ccc1N(CC1)CCN1C(CN(C(N1C=C2)=O)N=C1N=C2N1CCCC1)=O

InChI

InChI=1S/C22H27N7O3/c1-32-18-6-4-17(5-7-18)25-12-14-27(15-13-25)20(30)16-29-22(31)28-11-8-19(23-21(28)24-29)26-9-2-3-10-26/h4-8,11H,2-3,9-10,12-16H2,1H3

InChI Key

RDILWFFPGKSKBU-UHFFFAOYSA-N

MDL Number (MFCD)

MFCD27604772

Chemical and Physical Properties

Saltdata

n/a

Molecular Weight

437.5

Hydrogen Bond Acceptors Count

7.00

Hydrogen Bond Donors Count

0.00

Rotatable Bond Count

6.00

Number of Nitrogen and Oxygen Atoms

10

Partition Coefficient, logP

1.296

Distribution Coefficient, logD

1.295

Water Solubility, LogSw

-1.93

Polar Surface Area

72.618

Acid Dissociation Constant (pKa)

19.16

Base Dissociation Constant (pKb)

7.19

Number of Chiral Centers

0.00

Percent sp3 carbon bonding

45.50

P573-2162 in Drug Discovery

Included in Screening Libraries

GPCR Targeted Library (31838 compounds)

Serine Proteases Inhibitors Library (32732 compounds)

SmartTM Library (51161 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Musculoskeletal
  • Respiratory tract
  • Nervous system
  • Congenital
  • Skin
  • Metabolic
  • Endocrine
  • Infections
  • Cancer
  • Musculoskeletal
  • Digestive system
  • Respiratory tract
  • Male
  • Female
  • Cardiovascular
  • Skin
  • Metabolic
  • Immune system
Targets:
  • GPCR
  • Proteases
Mechanism of action:
  • Receptor's ligands

References: we are preparing a list of scientific research reports with P573-2162 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound P573-2162?
Check Price and Availability of P573-2162, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of P573-2162 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for P573-2162
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for P573-2162
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of P573-2162 available by request